Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
FDF
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Disodium Gadoxetate
2. Eovist
3. Gadolinium (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxylatomethyl)-3,6,9-triazaundecanoic Acid Disodium Salt
4. Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid
5. Gadolinium Ethoxybenzyl Dtpa
6. Gadoxetate Disodium
7. Gadoxetic Acid
8. Gadoxetic Acid Disodium
9. Gd-eob-dtpa
1. Eovist
2. Gadoxate
3. Gadoxate Disodium
4. Gadolinium Ethoxybenzyl-dtpa
5. Moli000482
6. Q1928394
7. 2-[[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-[2-[bis(carboxymethyl)amino]ethyl]amino]acetic Acid;gadolinium(3+)
8. Gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic Acid, Disodium S-[4-(4-ethoxybenzyl)-3,6,9-tris[(carboxy-ko)methyl]-3,6,9-triazaundecandioato)(5-)-k3n3,n6,n9,k2o1,o11]gadolinite(2-)
Molecular Weight | 684.8 g/mol |
---|---|
Molecular Formula | C23H33GdN3O11+3 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 14 |
Rotatable Bond Count | 20 |
Exact Mass | 685.13562 g/mol |
Monoisotopic Mass | 685.13562 g/mol |
Topological Polar Surface Area | 205 Ų |
Heavy Atom Count | 38 |
Formal Charge | 3 |
Complexity | 739 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Eovist |
PubMed Health | Gadoxetate (Injection) |
Drug Classes | Diagnostic Agent |
Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
Active Ingredient | Gadoxetate disodium |
Dosage Form | Solution |
Route | Intravenous |
Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
Market Status | Prescription |
Company | Bayer Hlthcare |
2 of 2 | |
---|---|
Drug Name | Eovist |
PubMed Health | Gadoxetate (Injection) |
Drug Classes | Diagnostic Agent |
Drug Label | EOVIST (gadoxetate disodium) is a paramagnetic contrast agent for MRI. EOVIST is provided as a sterile, clear, colorless to pale yellow aqueous solution for intravenous injection.EOVIST contains the active pharmaceutical ingredient gadoxetate disodiu... |
Active Ingredient | Gadoxetate disodium |
Dosage Form | Solution |
Route | Intravenous |
Strength | 1.8143gm/10ml (181.43mg/ml); 2.72145gm/15ml (181.43mg/ml) |
Market Status | Prescription |
Company | Bayer Hlthcare |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20414
Submission : 2007-05-14
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39660
Submission : 2024-04-01
Status : Active
Type : II
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm :
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm :
RLD : Yes
TE Code :
Brand Name : EOVIST
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 1.8143GM/10ML (181.43MG/ML)
Approval Date : 2008-07-03
Application Number : 22090
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : EOVIST
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 2.72145GM/15ML (181.43MG/ML)
Approval Date : 2013-02-04
Application Number : 22090
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
Regulatory Info :
Registration Country : Sweden
Brand Name : Primovist
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 0.25 MMOL / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Primovist
Dosage Form : SOLUTION FOR INJECTION, PRE-FILLED SYRINGE
Dosage Strength : 0.25 MMOL / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Primo Shown
Dosage Form : Injection fluid, resolution in the finished filled syringe
Dosage Strength : 0.25 mmol/ml
Packaging : Finish filled syringe of glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Primovist
Dosage Form : Inj Solution
Dosage Strength : 0.25mmol/ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Canada
Brand Name : PRIMOVIST
Dosage Form : SOLUTION
Dosage Strength : 181.43MG/ML
Packaging : 5ML/7.5ML/10ML
Approval Date :
Application Number : 2340666
Regulatory Info :
Registration Country : Canada
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Primovist
Dosage Form : SOL
Dosage Strength : 600mg
Packaging : 10X1mg/ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
A GADOXETATE DISODIUM manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GADOXETATE DISODIUM, including repackagers and relabelers. The FDA regulates GADOXETATE DISODIUM manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GADOXETATE DISODIUM API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of GADOXETATE DISODIUM manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A GADOXETATE DISODIUM supplier is an individual or a company that provides GADOXETATE DISODIUM active pharmaceutical ingredient (API) or GADOXETATE DISODIUM finished formulations upon request. The GADOXETATE DISODIUM suppliers may include GADOXETATE DISODIUM API manufacturers, exporters, distributors and traders.
click here to find a list of GADOXETATE DISODIUM suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A GADOXETATE DISODIUM DMF (Drug Master File) is a document detailing the whole manufacturing process of GADOXETATE DISODIUM active pharmaceutical ingredient (API) in detail. Different forms of GADOXETATE DISODIUM DMFs exist exist since differing nations have different regulations, such as GADOXETATE DISODIUM USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A GADOXETATE DISODIUM DMF submitted to regulatory agencies in the US is known as a USDMF. GADOXETATE DISODIUM USDMF includes data on GADOXETATE DISODIUM's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The GADOXETATE DISODIUM USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of GADOXETATE DISODIUM suppliers with USDMF on PharmaCompass.
A GADOXETATE DISODIUM written confirmation (GADOXETATE DISODIUM WC) is an official document issued by a regulatory agency to a GADOXETATE DISODIUM manufacturer, verifying that the manufacturing facility of a GADOXETATE DISODIUM active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting GADOXETATE DISODIUM APIs or GADOXETATE DISODIUM finished pharmaceutical products to another nation, regulatory agencies frequently require a GADOXETATE DISODIUM WC (written confirmation) as part of the regulatory process.
click here to find a list of GADOXETATE DISODIUM suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing GADOXETATE DISODIUM as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for GADOXETATE DISODIUM API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture GADOXETATE DISODIUM as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain GADOXETATE DISODIUM and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a GADOXETATE DISODIUM NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of GADOXETATE DISODIUM suppliers with NDC on PharmaCompass.
GADOXETATE DISODIUM Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GADOXETATE DISODIUM GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GADOXETATE DISODIUM GMP manufacturer or GADOXETATE DISODIUM GMP API supplier for your needs.
A GADOXETATE DISODIUM CoA (Certificate of Analysis) is a formal document that attests to GADOXETATE DISODIUM's compliance with GADOXETATE DISODIUM specifications and serves as a tool for batch-level quality control.
GADOXETATE DISODIUM CoA mostly includes findings from lab analyses of a specific batch. For each GADOXETATE DISODIUM CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GADOXETATE DISODIUM may be tested according to a variety of international standards, such as European Pharmacopoeia (GADOXETATE DISODIUM EP), GADOXETATE DISODIUM JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GADOXETATE DISODIUM USP).
LOOKING FOR A SUPPLIER?